CCA
MRK icon

Cadent Capital Advisors’s Merck MRK Stock Holding History

Cadent Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
2,978
+18
+0.6% +$2.11K 0.08% 139
2026
Q1 		$356K Buy
2,960
+19
+0.6% +$2.19K 0.09% 131
2025
Q4 		$310K Buy
2,941
+23
+0.8% +$2.16K 0.08% 145
2025
Q3 		$245K Buy
+2,918
New +$240K 0.06% 176
2025
Q1 		– Sell
-2,145
Closed -$213K – 155
2024
Q4 		$213K Buy
2,145
+9
+0.4% +$928 0.07% 143
2024
Q3 		$243K Sell
2,136
-577
-21% -$68.5K 0.07% 139
2024
Q2 		$336K Buy
2,713
+9
+0.3% +$1.16K 0.13% 93
2024
Q1 		$357K Sell
2,704
-207
-7% -$25.5K 0.14% 80
2023
Q4 		$317K Buy
2,911
+230
+9% +$23.9K 0.16% 79
2023
Q3 		$276K Buy
2,681
+10
+0.4% +$1.08K 0.11% 89
2023
Q2 		$308K Buy
2,671
+436
+20% +$49.5K 0.18% 85
2023
Q1 		$238K Buy
2,235
+10
+0.4% +$1.08K 0.11% 110
2022
Q4 		$247K Buy
+2,225
New +$227K 0.12% 103

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cadent Capital Advisors's MRK Position: Q2 2026 in Review

Cadent Capital Advisors increased its Merck (MRK) stake by 0.61% in Q2 2026, buying an estimated $2.11K and bringing the position to 2,978 shares worth $383K. The position accounts for 0.08% of the portfolio, ranked #139.

Cadent Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 13 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cadent Capital Advisors held 2,978 shares of Merck worth $383K as of Q2 2026.
  • Cadent Capital Advisors bought 18 Merck shares in Q2 2026, an estimated $2.11K.
  • Merck made up 0.08% of Cadent Capital Advisors's portfolio in Q2 2026, its #139 holding.
  • Cadent Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 13 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.